Literature DB >> 9456198

Can single photon emission computed tomography myocardial perfusion imaging monitor the potential benefit of aggressive treatment of hyperlipidemia?

R G Schwartz, T A Pearson.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9456198     DOI: 10.1016/s1071-3581(97)90016-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  34 in total

1.  Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation.

Authors:  A Corsini; M Raiteri; M R Soma; G Gabbiani; R Paoletti
Journal:  Clin Biochem       Date:  1992-10       Impact factor: 3.281

Review 2.  Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.

Authors:  K A Brown
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

3.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

4.  Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.

Authors:  B Pitt; G B Mancini; S G Ellis; H S Rosman; J S Park; M E McGovern
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

5.  Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits.

Authors:  J A Osborne; M J Siegman; A W Sedar; S U Mooers; A M Lefer
Journal:  Am J Physiol       Date:  1989-03

6.  Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease.

Authors:  D B Mark; L Shaw; F E Harrell; M A Hlatky; K L Lee; J R Bengtson; C B McCants; R M Califf; D B Pryor
Journal:  N Engl J Med       Date:  1991-09-19       Impact factor: 91.245

7.  Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia.

Authors:  H Drexler; A M Zeiher
Journal:  Hypertension       Date:  1991-10       Impact factor: 10.190

8.  Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population.

Authors:  R S Blumenthal; D M Becker; T F Moy; J Coresh; L B Wilder; L C Becker
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

Authors:  J W Jukema; A V Bruschke; A J van Boven; J H Reiber; E T Bal; A H Zwinderman; H Jansen; G J Boerma; F M van Rappard; K I Lie
Journal:  Circulation       Date:  1995-05-15       Impact factor: 29.690

View more
  3 in total

1.  Beyond the cholesterol profile: monitoring therapeutic effectiveness of statin therapy.

Authors:  R G Schwartz
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

2.  Third Annual Mario S. Verani, MD, Memorial Lecture: The future of clinical nuclear cardiology.

Authors:  Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

3.  What is this image? 2017: Image 4 result : Improvement of ischemia with statin therapy.

Authors:  Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.